Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05714202 |
|---|---|
| Brief Title: | A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) (SunRISe-3) |
| First Submitted : | January 27, 2023 |
| First Submitted that Met QC Criteria : | January 27, 2023 |
| First Posted : | February 6, 2023 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |